Literature DB >> 15828168

Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.

M I Marks.   

Abstract

Some of the variables in a microtiter tissue culture method for estimating antiviral susceptibility of herpes simplex viruses (HSV) were studied. Six antiviral drugs (5-iodo-2'-deoxyuridine, cytosine arabinoside, 9-beta-arabinofuranosyladenine, isoprinosine, virazole, and 2-deoxy-d-glucose) and three tissue culture cell lines (primary rabbit kidney, WI-38, and rat brain) were studied. Four different inocula (10, 100, 1,000, and 2,000 mean tissue culture doses) and nine isolates of HSV were tested. Minimal inhibitory concentration was defined as a complete inhibition of cytopathogenic effect in tissue culture cells after 72 h of incubation. There was a direct relationship between the viral inocula and the minimal inhibitory concentration. There were also differences between the three tissue culture cell lines and among the different strains of herpesvirus. This was not type specific, and the strain differences were not consistent in different tissue culture lines. Cytosine arabinoside appeared to be the most active drug in vitro, with 5-iodo-2'-deoxyuridine intermediate in activity between cytosine arabinoside and 9-beta-arabinofuranosyladenine; no significant cytotoxicity was encountered with these drugs. Isoprinosine, virazole, and 2-deoxy-d-glucose were not effective against any of the nine strains of HSV tested in this in vitro system; a comparison with previous studies indicates that their activity may be cell dependent. These results emphasize the importance of careful evaluation of in vitro test methods for the susceptibility testing of antiviral agents against HSV. Marked variability between strains and in vitro test systems caution against the application of these methods to in vivo situations until further studies are carried out.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15828168      PMCID: PMC429044          DOI: 10.1128/AAC.6.1.34

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE.

Authors:  D A BUTHALA
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

2.  Experimental animal model for encephalitis due to herpes simplex virus.

Authors:  M I Marks; S Carpenter
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

3.  Different effects of temperaturs on Type 1 and Type 2 Herpesvirus hominis in cell culture.

Authors:  J O Oh; N Schlenke
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

4.  The antiviral activity of isoprinosine.

Authors:  P Gordon; E R Brown
Journal:  Can J Microbiol       Date:  1972-09       Impact factor: 2.419

5.  Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.

Authors:  F J O'Neill; R J Goldberg; F Rapp
Journal:  J Gen Virol       Date:  1972-02       Impact factor: 3.891

6.  A serologic study of herpesvirus hominis strains by microneutralization tests.

Authors:  F P Pauls; W R Dowdle
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

7.  Effects of 2-deoxy-D-glucose on herpes simplex virus replication.

Authors:  R J Courtney; S M Steiner; M Benyesh-Melnick
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  J H Huffman; R W Sidwell; G P Khare; J T Witkowski; L B Allen; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

9.  Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine.

Authors:  D A Person; P J Sheridan; E C Herrmann
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

10.  Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.

Authors:  M Fiala; A Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  9 in total

1.  Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levels.

Authors:  D A Zaky; R F Betts; R G Douglas; K Bengali; G L Neil
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.

Authors:  J F Gephart; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

3.  Combined antiviral effect of DNA inhibitors on Herpes simplex virus multiplication.

Authors:  R Wigand; M Hassinger
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

Review 4.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

5.  Antiviral activity of sodium 5-aminosulfonyl-2,4-dichlorobenzoate (M12325).

Authors:  H Ohnishi; K Yamaguchi; S Shimada; S Himuro; Y Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.

Authors:  P M Schwartz; C Shipman; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

Review 7.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

8.  Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters.

Authors:  H E Renis
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

Review 9.  A Critical Review of Disinfection Processes to Control SARS-CoV-2 Transmission in the Food Industry.

Authors:  Adrián Pedreira; Yeşim Taşkın; Míriam R García
Journal:  Foods       Date:  2021-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.